Journal of Genetic Medicine

  • 제18권2호
  • /
  • Pages.117-120
  • /
  • 2021
  • /
  • 1226-1769(pISSN)
  • /
  • 2383-8442(eISSN)
대한의학유전학회 (Korean Society of Medical Genetics and Genomics)
권호 표지
DOI QR코드

DOI QR Code

Prenatal detection of Xq deletion by abnormal noninvasive prenatal screening, subsequently diagnosed by amniocentesis: A case report

  • Kim, Bo Ram (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Kim, Rina (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Cho, Angela (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Kang, Hye Sim (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Park, Chul Min (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Kim, Sung Yob (Department of Obstetrics and Gynecology, Jeju National University Hospital) ;
  • Shim, Soon Sup (Department of Obstetrics and Gynecology, Jeju National University Hospital)
  • 투고 : 2021.10.22
  • 심사 : 2021.12.05
  • 발행 : 2021.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

We experienced a case of Xq deletion -- 46,X,del(X)(q22.3) -- detected by abnormal noninvasive prenatal screening, subsequently diagnosed by amniocentesis. Genetic counseling was a challenge because there are few reports of prenatal diagnosis of Xq deletion. In each female cell, one X chromosome is inactivated at random early in development, and there may be a preferential inactivation of the abnormal X chromosome. But some proportions of genes escape inactivation. The most common manifestation in women with Xq deletion is primary or secondary ovarian failure. Critical regions for ovarian function may be located at the long arm of the X chromosome. But, the onset and the severity of ovarian failure may vary with diverse, intricate factors. We anticipate that noninvasive prenatal screening can identify the broader range of chromosomal or genetic abnormalities with the advances in technology and analytic methods. We report our case with a brief review of the literature.

키워드

참고문헌

  1. Brown LY, Alonso ML, Yu J, Warburton D, Brown S. Prenatal diagnosis of a familial Xq deletion in a female fetus: a case report. Prenat Diagn 2001;21:27-30. https://doi.org/10.1002/1097-0223(200101)21:1<27::AID-PD971>3.0.CO;2-R
  2. Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS Jr, Llerena JC Jr, et al. Deletion (X)(q26.1-->q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am J Hum Genet 1993;52:463-71.
  3. Ogata T, Matsuo N. Turner syndrome and female sex chromosome aberrations: deduction of the principal factors involved in the development of clinical features. Hum Genet 1995;95:607-29. https://doi.org/10.1007/BF00209476
  4. Simpson JL, Rajkovic A. Ovarian differentiation and gonadal failure. Am J Med Genet 1999;89:186-200. https://doi.org/10.1002/(SICI)1096-8628(19991229)89:4<186::AID-AJMG3>3.0.CO;2-5
  5. Krauss CM, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC. Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 1987;317:125-31. https://doi.org/10.1056/NEJM198707163170301
  6. Carrel L, Willard HF. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005;434:400-4. https://doi.org/10.1038/nature03479
  7. Kohn M, Kehrer-Sawatzki H, Vogel W, Graves JA, Hameister H. Wide genome comparisons reveal the origins of the human X chromosome. Trends Genet 2004;20:598-603. https://doi.org/10.1016/j.tig.2004.09.008
  8. Lahn BT, Page DC. Four evolutionary strata on the human X chromosome. Science 1999;286:964-7. https://doi.org/10.1126/science.286.5441.964
  9. Madan K. Balanced structural changes involving the human X: effect on sexual phenotype. Hum Genet 1983;63:216-21. https://doi.org/10.1007/BF00284652
  10. Mattei MG, Mattei JF, Ayme S, Giraud F. X-autosome translocations: cytogenetic characteristics and their consequences. Hum Genet 1982;61:295-309. https://doi.org/10.1007/BF00276593
  11. Sarto GE, Therman E, Patau K. X inactivation in man: a woman with t(Xq--;12q+). Am J Hum Genet 1973;25:262-70.
  12. Shelling AN. Premature ovarian failure. Reproduction 2010;140:633-41. https://doi.org/10.1530/REP-09-0567
  13. Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann N Y Acad Sci 2008;1135:146-54. https://doi.org/10.1196/annals.1429.019
  14. Eggermann T, Meschede D, Schuler H, Palm S, Glaser D, Horsthemke B, et al. Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet 2005;67:434-7. https://doi.org/10.1111/j.1399-0004.2005.00427.x
  15. Rossetti F, Rizzolio F, Pramparo T, Sala C, Bione S, Bernardi F, et al. A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 2004;12:829-34. https://doi.org/10.1038/sj.ejhg.5201186
  16. Skibsted L, Westh H, Niebuhr E. X long-arm deletions. A review of non-mosaic cases studied with banding techniques. Hum Genet 1984;67:1-5. https://doi.org/10.1007/BF00270550
  17. American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics; Committee on Genetics; Society for Maternal-Fetal Medicine. Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet Gynecol 2020;136:e48-69. https://doi.org/10.1097/AOG.0000000000004084
  18. Van Den Bogaert K, Lannoo L, Brison N, Gatinois V, Baetens M, Blaumeiser B, et al. Outcome of publicly funded nationwide first-tier noninvasive prenatal screening. Genet Med 2021;23:1137-42. https://doi.org/10.1038/s41436-021-01101-4